Get complete information related to latest Scientific Journal Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Scientific Journal Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Scientific Journal Tenders.
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapidexchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientificjournals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of thestent to a major government institute. unit:no [ warranty period: 30 months after the date of delivery ] ]
Tender For supply of drug eluting stent -sirolimous drug with biodegrable polymer on cobalt chromium platform with active coating. size ranging from length 08 mm to 48 mm and width 2.25 mm to 5.0 mm. the quoted stent to be at least dcgi approved and three years efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented/published in peer reviewed scientificjournals. the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid. replacement warranty against any manufacturing defect noted onthe o.t. table. the original company brochure mentioning the range of sizes (diameter & length) should besubmitted along with tender. [ai(2026-27), item code-no: s-62066, sl no.2010] ]
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus, everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval shouldbe enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientificjournals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent toa major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For srphc82281215-coronary drug eluting stents (1) with single wire design with cobalt alloy shell and platinum iridium core (2) stent with coating of biolinx polymer carrier for active drug zotarolimus shown to be effective in preventing neo-intimal hyperplasia (3) stent diameter should be from 2 mm to 5mm and length of the stent from 8 mm to 38 mm. (4) the strut should be round with thickness ranging from 81 to 91 microns (5) stent delivery system should be monorail (single operator exchange or rapidexchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) five years efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientificjournals.(10) the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. ]